Virani Shafique

CIK 00018560811 companySALT LAKE CITY, UT

SEC Profile

Transactions

Companies

Filings

CIK

0001856081

Recent Transactions

50 trades

Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-01-16$2.22/sh+18,000→ 154,748 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-01-16−18,000→ 361,469 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-01-16$10.93/sh−18,000→ 136,748 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-12-15$2.22/sh+18,000→ 154,748 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2023-12-15−18,000→ 379,469 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-12-15$9.60/sh−18,000→ 136,748 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-11-15$2.22/sh+18,000→ 158,351 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2023-11-15−18,000→ 397,469 total
Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-11-15$7.18/sh−3,603→ 136,748 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-11-15$6.51/sh−18,000→ 140,351 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2023-10-16−18,000→ 415,469 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-10-16$2.22/sh+18,000→ 158,351 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-10-16$6.30/sh−18,000→ 140,351 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2023-09-15−18,000→ 433,469 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-09-15$2.22/sh+18,000→ 158,351 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-09-15$8.66/sh−18,000→ 140,351 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2023-08-15−18,000→ 451,469 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-08-15$9.25/sh−18,000→ 140,351 total
Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-08-15$9.19/sh−3,603→ 140,351 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-08-15$2.22/sh+18,000→ 158,351 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2023-07-26−20,000→ 469,469 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-07-26$14.41/sh−20,000→ 143,954 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-07-26$2.22/sh+20,000→ 163,954 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-07-25$14.30/sh−20,000→ 143,954 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-07-25$2.22/sh+20,000→ 163,954 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2023-07-25−20,000→ 489,469 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2023-07-18−30,000→ 509,469 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-07-18$13.74/sh−30,000→ 143,954 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-07-18$2.22/sh+30,000→ 173,954 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2023-07-17−30,000→ 539,469 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-07-17$11.72/sh−30,000→ 143,954 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-07-17$2.22/sh+30,000→ 173,954 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-06-16$2.22/sh+30,000→ 173,954 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2023-06-16−30,000→ 569,469 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-06-16$9.41/sh−30,000→ 143,954 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2023-06-15−30,000→ 599,469 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-06-15$2.22/sh+30,000→ 173,954 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-06-15$9.67/sh−30,000→ 143,954 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-06-02$8.93/sh−17,865→ 143,954 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-06-01$8.58/sh−25,000→ 161,819 total
Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-05-15$5.60/sh−2,230→ 185,102 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-02-16$8.42/sh−1,768→ 187,332 total
Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-02-15$8.44/sh−746→ 189,100 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-02-15$8.33/sh−7,486→ 189,846 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2023-02-15+7,486→ 629,469 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-02-15$2.22/sh+7,486→ 197,332 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-02-01+106,253→ 182,003 total
Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-02-01$8.55/sh−2,994→ 189,846 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-02-01+10,837→ 192,840 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2023-02-01+212,507→ 212,507 total

Companies

RECURSION PHARMACEUTICALS, INC.
Chief Corp. Dev. Officer
$RXRX

Recent Filings

Address

C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET

SALT LAKE CITY, UT, 84101

View on SEC.gov